iANTHUS CAPITAL HOLDINGS (ITHUF) Return on Capital Employed (2021 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Return on Capital Employed came in at 8.53% in Q1 2026, down 731.0% year-on-year from 1.35% in Q1 2025, and down 3.72% quarter-over-quarter from 8.22% in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Return on Capital Employed (2021 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Return on Capital Employed across 6 years of filings, most recently posting 8.53% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 8.53%, down 731.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 8.53% (down 731.0% YoY), and the FY2025 annual result was 7.91%, down 523.0% from the prior year.
- Return on Capital Employed came in at 8.53% for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from 8.22% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 2.24% in Q3 2024 to a low of 83.56% in Q1 2022.
- The 5-year median for Return on Capital Employed is 8.37% (2023), against an average of 22.79%.
- Across the five-year window, Return on Capital Employed plunged 5333 bps in 2022 and jumped 5443 bps in 2024, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Return on Capital Employed stood at 48.23% in 2022, then surged by 83 bps to 8.37% in 2023, then surged by 68 bps to 2.71% in 2024, then sank by 203 bps to 8.22% in 2025, then declined by 4 bps to 8.53% in 2026.
- The last three Return on Capital Employed figures came in at 8.53% (Q1 2026), 8.22% (Q4 2025), and 5.47% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.52% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 27.58% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.43% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 20.04% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 7.34% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 6.92% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -1.92% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 14.85% |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -8.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.53% |
| Dec 31, 2025 | -8.22% |
| Sep 30, 2025 | -5.47% |
| Jun 30, 2025 | -3.92% |
| Mar 31, 2025 | -1.22% |
| Dec 31, 2024 | -2.71% |
| Sep 30, 2024 | 2.24% |
| Jun 30, 2024 | -2.03% |
| Mar 31, 2024 | -5.93% |
| Dec 31, 2023 | -8.37% |
| Sep 30, 2023 | -43.21% |
| Jun 30, 2023 | -42.84% |
| Mar 31, 2023 | -60.36% |
| Dec 31, 2022 | -48.23% |
| Sep 30, 2022 | -34.48% |
| Jun 30, 2022 | -30.56% |
| Mar 31, 2022 | -83.56% |
| Dec 31, 2021 | -34.37% |
| Sep 30, 2021 | -17.70% |
| Jun 30, 2021 | -20.78% |